Keywords: BRVO; branch retinal vein occlusion; CAT; cube average thickness; CRVO; central retinal vein occlusion; CST; central subfield thickness; CV; cube volume; EZ; ellipsoid zone; HRVO; Hemiretinal vein occlusion; ME; macular edema; RPE; retinal pigment epithel
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AMD; age-related macular degeneration; approxETDRS; approximate Early Treatment Diabetic Retinopathy Study; CRT; central retinal thickness; CRVO; central retinal vein occlusion; logMAR; logarithm of the minimum angle of resolution; PRN; pro re nata; PRP;
Keywords: AMD; age-related macular degeneration; BRVO; branch retinal vein occlusion; CI; confidence interval; CRVO; central retinal vein occlusion; ETDRS; Early Treatment Diabetic Retinopathy Study; HRVO; hemiretinal vein occlusion; QALY; quality-adjusted life-yea
Keywords: AV; arteriovenous; BCVA; best-corrected visual acuity; BRAVO; RanibizumaB for the treatment of macular edema following bRAnch retinal Vein Occlusion; BRVO; branch retinal vein occlusion; BVOS; Branch Vein Occlusion Study; CFT; central foveal thickness; CP
Keywords: ARN; acute retinal necrosis; ASCRS; American Society of Cataract and Refractive Surgery; ASRS; American Society of Retina Specialists; CRVO; central retinal vein occlusion; HORV; hemorrhagic occlusive retinal vasculitis; IOL; intraocular lens; NLP; no lig
Keywords: BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; PRN; pro re nata; RELATE; Ranibizumab Dose Comparison (0.5 mg and 2.0 mg) and the Role of Laser in the Management of Retinal Vein Occlusion; RNP; retinal nonperfusion; RVO; retinal
Keywords: BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; DME; diabetic macular edema; HARBOR; Phase III, Double-Masked, Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Sa
Keywords: BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; CST; central subfield thickness; DR; diabetic retinopathy; DRIL; disorganization of the retinal inner layers; ETDRS; Early Treatment Diabetic Retinopathy Study; EZ; ellipsoid zone;
Keywords: BRVO; branch retinal vein occlusion; CI; confidence interval; CRVO; central retinal vein occlusion; HR; hazard ratio; ICD; International Classification of Diseases; ICD-9-CM; International Classification of Diseases, 9th Revision, Clinical Modification; K
Keywords: AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; CST; central subfield thickness; OCT; optical coherence tomography; PRN; pro re nata; RBZ; ranibizumab; R
Keywords: DM; Diabetes Mellitus; DR; Diabetic Retinopathy; NPDR; Non-Proliferative Diabetic Retinopathy; PDR; Proliferative Diabetic Retinopathy; ME; Macular Edema; MA; Microaneurysms; HA; Haemorrhages; CWS; Cotton Wool Spots; VB; Venous Beading; NV; Neovasculariza
Keywords: BCVA; best-corrected visual acuity; CNP; capillary nonperfusion; CRA; central retinal artery; CRV; central retinal vein; CRVO; central retinal vein occlusion; CVBS; Central Vein Bypass Study; CVP; central venous pressure; DA; disc area; ETDRS; Early Treat
Keywords: aHR; adjusted hazard ratio; BRVO; branch retinal vein occlusion; CHF; congestive heart failure; CRVO; central retinal vein occlusion; CVA; cerebrovascular disease; DM; diabetes mellitus; HCS; hypercoagulable state; HTN; hypertension; ICD-9-CM; Internation
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; BRAVO; Treatment of Macular Edema following Branch Retinal Vein Occlusion: Evaluation of Efficacy and Safety; BRVO; branch retinal vein occlusion; CRUISE; Treatment of Macular Edema following Central
Keywords: endothelium; optic nerve; lamina cribrosa; central retinal vein; central retinal artery; CRAO; central retinal artery occlusion; CRVO; central retinal vein occlusion; e; distance from cell apex to nucleus in the downstream direction of blood flow; ANCOVA;
Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study
Keywords: BCVA; best-corrected visual acuity; CME; cystoid macular edema; CRVO; central retinal vein occlusion; CST; central subfoveal retinal thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; IAI; intravitreal aflibercept injection; PRN; pro re nata; S
Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; CFT; central foveal thickness; CRC; central reading center; CRVO; central retinal vein occlusion; CSFT; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; FAS; full analysi
Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study
Keywords: BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CLS-TA; triamcinolone acetonide; CRVO; central retinal vein occlusion; CST; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; HRVO; hemiretinal vein occl
SCORE2 Report 2
Keywords: AMD; age-related macular degeneration; anti-VEGF; anti-vascular endothelial growth factor; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; EDCCS; Eye Disease Case-Control Study; E-ETDRS; electronic Early Treatment Diabetic Ret
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials
Keywords: APTC; Anti-Platelet Trialists Collaboration; ATE; arterial thromboembolic event; BRVO; branch retinal vein occlusion; CI; confidence interval; CRVO; central retinal vein occlusion; DME; diabetic macular edema; HTN; hypertension; IAI; intravitreal afliberc
Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; CRC; central reading center; CRVO; central retinal vein occlusion; CSFT; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; EU SmPC; 2011 Lucentis European Union Summary of
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
Keywords: AE; adverse event; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CRT; central retinal thickness; CRVO; central retinal vein occlusion; ETDRS; Early Treatment Diabetic Retinopathy Study; HRVO; hemi-retinal vein occlusion; IAI; in
Therapies for Macular Edema Associated with Central Retinal Vein Occlusion
Keywords: BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CFT; central foveal thickness; COPERNICUS; Vascular Endothelial Growth Factor [VEGF] Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion [CRVO]; CRUISE;
Neutralization of Vascular Endothelial Growth Factor Slows Progression of Retinal Nonperfusion in Patients with Diabetic Macular Edema
Keywords: BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; DA; disc area; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; RBZ; ranibizumab; RNP; retinal nonperfusion; RVO; retinal vein occlusion; VEGF; vascu
Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion
Keywords: BCVA; best-corrected visual acuity; CRT; central retinal thickness; CRUISE; Central Retinal Vein Occlusion Study: Evaluation of Efficacy and Safety; CRVO; central retinal vein occlusion; IAI; intravitreal aflibercept injection; NEI VFQ-25; National Eye In
Une cause rare d'occlusion de la veine centrale de la rétine chez le sujet jeune dans un contexte traumatique
Keywords: Sujet jeune; Blast; OVCR; Mutation; G20210A du facteur II; Young subject; Blast; CRVO; Mutation; Factor II G20210A;
Uncommon ophthalmologic disorders in intensive care unit patients
Keywords: ICU; intensive care unit; CASP; critical appraisal skills programme; APAC; acute primary angle closure; IOP; intraocular pressure; NMB; neuromuscular blockers; CNS; central nervous system; CRAO; central retinal artery occlusion; CRVO; central retinal vein